Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ADVISORY, May 24, 2013 (GLOBE NEWSWIRE) -- What: Opexa Therapeutics, Inc. [OPXA], a biotechnology company developing TcelnaTM, a patient specific T-cell immunotherapy for the treatment of multiple sclerosis (MS), will visit the NASDAQ MarketSite in Times Square. In honor of World MS Day, Neil K. Warma, President & Chief Executive Officer will ring the Closing Bell.
Help employers find you! Check out all the jobs and post your resume.
